Archival of Human Biological Samples in CU-Med Biobank
Launched by CHINESE UNIVERSITY OF HONG KONG · Jan 11, 2021
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The CU-Med Biobank trial is focused on collecting and sharing human biological samples, like blood and tissue, to support important scientific research. This research will help scientists learn more about various health conditions, including cancer, heart diseases, neurological issues, kidney diseases, diabetes, and other diseases. The study is currently recruiting participants of all ages and genders who are willing to provide their samples and related health information.
To be eligible for this trial, participants must agree to give their signed consent for their samples and personal health information (which will be kept private) to be collected, stored, and shared with researchers. If you decide to participate, you can expect to provide a sample and sign a consent form, which helps ensure that your information is used properly for research purposes. Your participation could contribute to advancing our understanding of health issues and improving treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled subjects that have provided signed consent for the specimens and de-identified data to be collected, stored and distributed.
- Exclusion Criteria:
- • Subjects without signed informed consent for the specimens and de-identified data to be collected, stored and distributed.
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Ching Wan MA, MB BChir
Study Chair
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials